[e-drug] Conference: Risks of counterfeits in importation

["Bryan Liang" <baliang@alum.mit.edu>]

E-DRUG: Conference: Risks of counterfeits in importation
----------------------------------------

hi all,
this might be a conference of interest to people on drug 
importation, a huge policy issue for us in the USA

Bryan Liang
baliang@alum.mit.edu

*************************************************
Partnership for Safe Medicines
http://www.safemedicines.org
**************************************************

The Institute for Health Law Studies is pleased to announce its 
upcoming health policy conference: "INTERNATIONAL DRUG IMPORTATION: 
ISSUES IN PUBLIC POLICY, PATIENT SAFETY, AND THE PUBLIC HEALTH." at 
the Shelter Pointe Hotel, San Diego, CA from June 3-4, 2005

One of the most pressing policy issues today is access to safe and 
affordable medicines. International drug importation has been 
proposed as a solution to address this policy goal. Yet a plethora of 
policy, safety, and public health concerns all impact if and how 
importation could be a viable alternative for effective patient 
access to medications. Few of these concerns have been discussed 
together by stakeholders within the same forum. In response to this 
critical need, the Institute of Health Law Studies is pleased to 
convene the Health Policy Conference, "International Drug 
Importation: Issues in Public Policy, Patient Safety, and the Public 
Health", which will bring these stakeholder groups together to 
discuss the public policy, health, and safety issues surrounding drug 
importation. The goal is an informed debate through education and 
discussion by leading medical, legal, policy, safety, and consumer 
experts in the field.

This program will bring together national representatives of 
stakeholder groups, including the medical, legal, industry, safety, 
policy, and consumer communities. Confirmed speakers of special 
interest include David Lee, counsel and therapeutic liason branch 
Health Canada, Aaron Graham of Purdue Pharma and former Drug 
Enforcement Agency Senior Special Agent, Scott McKibbin, Speical 
Advocate for Prescrition Drugs, Illinois Governor's Office who began 
the Canadian drug purchase program for state employees, Edward 
Langston, American Medical Association Trustee who is both a 
physician and a pharmacist, and U.S. Attorney Carolyn Lam, who 
successfully prosecuted the case of a counterfeiter who was smuggling 
fakes into the U.S.

For attendees, the registration fee is only $125. Sponsorship 
opportunities are available from $1,000-$20,000. Online registration, 
full speaker list, and hotel discount information is available at: 
http://www.cwsl.edu/main/default.asp?nav=ihls.asp&body=ihls/conference.asp. 

For more information, please contact Pam Tait at the Institute of 
Health Law Studies at (619) 515-1568.

This conference is partially underwritten by the Castetter Endowment Fund.

************
Information on the Partnership

The Partnership for Safe Medicines is a network of organizations 
concerned about consumer safety risks associated with purchasing 
prescription medicines from potentially unsafe sources, including 
importation of medicines from illegal unlicensed storefront drugs 
sellers and illegal unlicensed internet drug sellers.

For more information on the Partnership, please visit our web site at 
http://www.safemedicines.org